Harbor–UCLA Medical Center

Lundquist Institute Investigator Dr. Loren Miller to Receive 2024 Top Ten Clinical Research Achievement Award from the Clinical Research Forum

Retrieved on: 
Thursday, February 15, 2024
Infection, Human services, Chlorhexidine, Paris Las Vegas, University of California, Irvine, Nursing, TLI, Harbor–UCLA Medical Center, Physiology, Agency, Conference, Disease, Interim, Health, Tufts University, University, UC, MPH, Clinical trial, Diagnosis, Science, UCLA, Nose, Pharmaceutical industry

Los Angeles, California, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is pleased to announce that Lundquist Investigator Loren Miller, MD, MPH will be honored with a 2024 Top Ten Clinical Research Achievement Award

Key Points: 
  • Los Angeles, California, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is pleased to announce that Lundquist Investigator Loren Miller, MD, MPH will be honored with a 2024 Top Ten Clinical Research Achievement Award
    by the Clinical Research Forum (CR Forum) at a ceremony in Las Vegas, NV on April 2, 2024.
  • The Top 10 Clinical Research Achievement Awards honor groundbreaking achievements in clinical research nationwide.
  • The award recognizes the Protect Trial, a clinical trial jointly led by Dr. Miller and senior investigator Susan Huang, MD, MPH, Chancellor’s Professor at the University of California, Irvine.
  • “I am pleased to congratulate Dr. Loren Miller on receiving this prestigious award from the Clinical Research Forum,” said Dr. Marianne Gausche-Hill, Interim President and CEO of The Lundquist Institute.

SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 against Mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis Conference

Retrieved on: 
Monday, January 29, 2024
Mortality, Patient, Leukemia, LAMB, Therapy, MD, FCCP, Infection, Biotechnology, Survival, Fungal infection, COVID, FAAM, Aspergillosis, Division, Immunodeficiency, Conference, Bone marrow, UCLA, Transplant, B♭ (musical note), Doctor of Philosophy, Antimalarial medication, FIDSA, Harbor–UCLA Medical Center, Lung, AAAM, Diabetes, Pharmaceutical industry

In this highly lethal mouse model of mucormycosis, SCY-247 showed very promising in vivo efficacy.

Key Points: 
  • In this highly lethal mouse model of mucormycosis, SCY-247 showed very promising in vivo efficacy.
  • This is comparable to the 40% survival observed in the control group treated with 10 mg/kg of intravenous standard of care of liposomal amphotericin B (LAMB) (p = 0.008 vs. placebo).
  • The combination treatment of SCY-247 plus LAMB demonstrated the greatest reduction in fungal burden and was highly statistically significant in both lung and brain tissue (both p
  • “These positive data continue to accumulate and define the unique properties of SCY-247, highlighting its potential to be differentiated from currently available antifungals.

Apollo Medical Holdings, Inc. Announces Leadership Transitions

Retrieved on: 
Wednesday, January 24, 2024
Internal medicine, Howard University, CFO, University, DaVita Inc., CMO, Vice, Harbor–UCLA Medical Center, Population health, Growth, Management

Dr. Dinesh Kumar will be joining the executive team as Chief Medical Officer of ApolloMed, effective January 23, 2024.

Key Points: 
  • Dr. Dinesh Kumar will be joining the executive team as Chief Medical Officer of ApolloMed, effective January 23, 2024.
  • Prior to his appointment as CMO of ApolloMed, Dr. Kumar served as Chief Medical and Chief Operating Officer at Alignment Healthcare.
  • Dr. Kumar received his medical degree from the University of Madras and completed his residency in internal medicine at Howard University.
  • He then completed his fellowship in pulmonary and critical care medicine at Harbor-UCLA Medical Center and completed a Health Care Leadership Program at the University of California-San Francisco.

Novel Technology Transforms Baldness Treatment Using Beard and Body Hair

Retrieved on: 
Monday, January 8, 2024
Scalp, BHT, Division, Transplant, FUE, Hair loss, Harbor–UCLA Medical Center, Surgeon, Skin, Eyebrow, Specialization, Eyelash, Patient, Wound healing, Cosmetics

LOS ANGELES, Jan. 8, 2024 /PRNewswire/ -- The ongoing puzzle of having lots of body hair but little on the scalp has confounded many dealing with hair loss.

Key Points: 
  • LOS ANGELES, Jan. 8, 2024 /PRNewswire/ -- The ongoing puzzle of having lots of body hair but little on the scalp has confounded many dealing with hair loss.
  • A breakthrough emerges with Dr. U Hair and Skin Clinic reports a pioneering study published in the esteemed Dermatologic Surgery journal titled ' Beard and Body Hair Transplantation by Follicular Unit Excision Using a Skin-Responsive Device .'
  • This publication introduces the revolutionary UGraft Zeus®, a novel skin-responsive device empowering doctors to seamlessly relocate beard and body hair to bald areas on the scalp through a procedure known as body hair transplantation (BHT).
  • Specialized transplants like eyebrows, beards, and eyelashes achieve more natural aesthetic results by utilizing matched body hair characteristics compared to thick but unmatched scalp hair.

Novel Technology Transforms Baldness Treatment Using Beard and Body Hair

Retrieved on: 
Monday, January 8, 2024
Scalp, BHT, Division, Transplant, FUE, Hair loss, Harbor–UCLA Medical Center, Surgeon, Skin, Eyebrow, Specialization, Eyelash, Patient, Wound healing, Cosmetics

LOS ANGELES, Jan. 8, 2024 /PRNewswire/ -- The ongoing puzzle of having lots of body hair but little on the scalp has confounded many dealing with hair loss.

Key Points: 
  • LOS ANGELES, Jan. 8, 2024 /PRNewswire/ -- The ongoing puzzle of having lots of body hair but little on the scalp has confounded many dealing with hair loss.
  • A breakthrough emerges with Dr. U Hair and Skin Clinic reports a pioneering study published in the esteemed Dermatologic Surgery journal titled ' Beard and Body Hair Transplantation by Follicular Unit Excision Using a Skin-Responsive Device .'
  • This publication introduces the revolutionary UGraft Zeus®, a novel skin-responsive device empowering doctors to seamlessly relocate beard and body hair to bald areas on the scalp through a procedure known as body hair transplantation (BHT).
  • Specialized transplants like eyebrows, beards, and eyelashes achieve more natural aesthetic results by utilizing matched body hair characteristics compared to thick but unmatched scalp hair.

Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease

Retrieved on: 
Tuesday, January 2, 2024
Division, Cosmetic, Research, FUE, Harbor–UCLA Medical Center, Surgeon, Trial of the century, Intelligence, Transplant, Patient, Clinical, Skin

The newly introduced UGraft Zeus® device significantly streamlines the procedure, making it faster and easier while minimizing graft damage.

Key Points: 
  • The newly introduced UGraft Zeus® device significantly streamlines the procedure, making it faster and easier while minimizing graft damage.
  • It resulted in a lower graft damage rate (2.2-4.3%) compared to previously published studies (5.6% - 9.2%), alongside an unprecedented 87% long hair graft retrieval.
  • The device's versatility was further demonstrated in the study by its success in performing no-shave long hair FUE in black patients of African descent, who are typically deemed challenging in even shaved head FUE procedures.
  • The UGraft Zeus® now extends hope to patients unable to shave their heads due to lifestyle or cost constraints in accessing long hair FUE.

Dr. David Shavelle Named Chief of Cardiology at MemorialCare - Serving as Liaison Between Hospital Administration, Medical Staff and Clinical Leaders

Retrieved on: 
Thursday, December 14, 2023
UCLA, USC, Joint Medical Service (Germany), Harbor, Research, Private practice, Good Samaritan Hospital, Scar, Mechanical engineering, Patient, Catheter, Faculty, Division, Heart, Interventional cardiology, Internal medicine, Caregiver, Rehabilitation, Health, Intervention, Golden Apple Award, Los, University, Physician, UC, Golden Apple Award (education), Harbor–UCLA Medical Center, Mechanical, University of California, Irvine, Education, Medical imaging, Cardiology

FOUNTAIN VALLEY, Calif., Dec. 14, 2023 /PRNewswire/ -- MemorialCare, a prominent nonprofit Southern California integrated health system, announced today that David Shavelle, M.D. has been named the Chief of Cardiology for the entire health system. In his new role, Dr. Shavelle will serve as a liaison between Los Angeles' and Orange County's medical staffs, hospital administrations, physicians and clinical teams across MemorialCare's entire footprint – advancing the vision and mission of the MemorialCare Heart & Vascular Institute throughout the health system.

Key Points: 
  • has been named the Chief of Cardiology for the entire health system.
  • Dr Shavelle will be responsible for leading MemorialCare Heart & Vascular Institute's general and specialty cardiology, interventional cardiology, advanced interventional modalities such as structural heart, complex coronary, ventricular support, research, and clinical trials system wide.
  • Dr. Shavelle will also keep his current role as medical director of adult cardiology and interventional lab, at MemorialCare Long Beach Medical Center.
  • "I am humbled and honored to become the Chief of Cardiology for MemorialCare," says Dr. Shavelle.

The Inner Circle Acknowledges, Mark Plunkett as a Distinguished Medical Professional for his contributions to the field of Pediatric Cardiac Surgery

Retrieved on: 
Monday, October 30, 2023
CASA, Cross My Heart and Hope to Die (film), American College, Corazón, Duke University, Ronald Reagan UCLA Medical Center, Harbor–UCLA Medical Center, Life, Ventricular septal defect, Congenital Heart Surgeons' Society, Cardiothoracic surgery, American Heart Association, Hope, AMA, Multimedia, University of North Carolina at Pembroke, ABTS, Physician, The Washington Campus Board of Directors, Inner circle, Hospital Sisters Health System, University, Travel, Society, Patient, Hospital, Society of Thoracic Surgeons, Dentistry, Biology

PEORIA, Ill., Oct. 30, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mark Plunkett is acknowledged as a Distinguished Medical Professional for his contributions to the field of Pediatric Cardiac Surgery.

Key Points: 
  • PEORIA, Ill., Oct. 30, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mark Plunkett is acknowledged as a Distinguished Medical Professional for his contributions to the field of Pediatric Cardiac Surgery.
  • Dr. Plunkett began his higher education journey at Duke University where he earned a Bachelor of Science degree in Biology.
  • He then attended the University of North Carolina and earned a Medical Doctor degree; completed a residency in general and cardiothoracic surgery at Duke University, a nine-year program; and a fellowship in pediatric and congenital heart surgery at UCLA Medical Center/ Mattel Children's Hospital.
  • Board certified by the ABTS in cardiothoracic surgery and congenital heart surgery, Dr. Plunkett specializes in treating fetuses; infants; children; and adolescents with cardiovascular or cardiac abnormalities.

CORRECTION: Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New England Journal of Medicine

Retrieved on: 
Wednesday, October 11, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, University, CDC, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Nursing home, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

The findings were published on October 10, 2023, in the New England Journal of Medicine.

Key Points: 
  • The findings were published on October 10, 2023, in the New England Journal of Medicine.
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • “Nursing Home Decolonization for Infection and Hospitalization Prevention” published in the New England Journal of Medicine on October 10, 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2215254?query=featured_home

Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New English Journal of Medicine

Retrieved on: 
Tuesday, October 10, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, CDC, University, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

“The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.

Key Points: 
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • Each year, 3 million healthcare-associated infections (HAIs) such as methicillin-resistant Staphylococcus aureus (MRSA), bloodstream and urinary tract infections occur in U.S. nursing homes.
  • The findings add to a growing body of Dr. Miller’s research that has been funded by NIH, AHRQ, and other federal sources.